Head-to-head · WeighScore
CoreAge Rx vs NovoCare Pharmacy
By GLP-1 ScorecardUpdated
Score comparison
CoreAge Rx has the higher recorded score — 89.5/100 to 55.2/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | NovoCare Pharmacy |
|---|---|---|
| WeighScore | 89.5/100 | 55.2/100 |
| Grade | B+ | C |
| Site position | #1 | #491 |
| Semaglutide | Product page from $79/mo; navigation $99. Confirm selected quote. | Branded Wegovy injection: $349 standard fill (4 pens / 28 days); starter, HD and tablet offers vary by dose and eligibility. |
| Tirzepatide | From $129/mo advertised; confirm selected charge, supply and renewal. | Not disclosed |
| Coverage | US only; therapy-specific state restrictions apply | BlinkRx network pharmacies collectively cover 50 states, DC and Puerto Rico; confirm the assigned dispenser and eligibility. |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Yes |
Site position #1 · B+
Strengths
- Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
- Advertises the same price across doses and no membership fee
- Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy
What to consider
- Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
- FAQ no-rebill and payment-timing statements differ from the subscription and order policy
- FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
- Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
- Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Site position #491 · C
Strengths
- Names BlinkRx and legacy pharmacy arrangements rather than leaving the fulfillment route anonymous.
- Publishes a two-fill $199 Wegovy injection starter offer with specific eligibility and prescription/shipping deadlines.
- Publishes dose-specific Wegovy tablet and injection self-pay offers for comparison.
- Advertises free home delivery powered by BlinkRx.
- Provides independent prescriber options as well as delivery and pharmacy-pickup information.
What to consider
- Reviewed offers cover branded semaglutide products, including Wegovy and Ozempic; no tirzepatide or compounded offer was established.
- A prescription is required; linked independent care does not establish included visits or follow-up.
- The medication offer does not establish an included prescriber follow-up plan or a complete selected-order refund agreement.
- Manufacturer-set pricing can change at any time
- Eligible Wegovy injection starter pricing covers two 28-day fills under the delivery offer’s December 31, 2026 prescription and January 31, 2027 shipping deadlines; standard pricing follows.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.